ClinicalTrials.gov
public full text
Public Domain
IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume
The present register has been designed to confirm the hypothesis that while using high quality Intensity Modulated Radiation Techniques (IMRT) and a reduced external beam stereotactic boost component it would be possible to maintain the late severe toxicity rates under the 5 % level in situations where brachytherapy could not be proposed as a boost.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- AI for Head Neck Cancer Treated With Adaptive RadioTherapy (RadiomicART)#1059442
- Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)#890537
- High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy#910778
- CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer#837353
- Deep learning-based dose prediction for stereotactic prostate cancer radiotherapy with CyberKnife.#1166994
Record · ID 1162714
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive